English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The anti-tumor effects of cisplatin and valproic acid have provided a new opportunity in the treatment of ovary tumor cell line. Objectives: In this survey, the cytotoxic and apoptotic effects of cisplatin and valproic acid on the human ovary tumor cell line (ovar-3) was investigated. Materials and Methods: In this study three groups were compared with the control group. Groups 1, 2 and 3 were studied with cisplatin, valproic acid and both of cisplatin and valproic acid respectively on ovary cell line (ovar-3). Each drug concentration was a spectrum between 1 to 1000 MM. The exposure time of ovar-3 ovary cells with the drugs was 36 hours. The MTT test for the live cell monitoring was performed with anexinPropidium iodide (PI). Results: The IC50 for each cisplatin, valproic acid and the mixture of these compounds were 3.3 mm, 33 mm and 0.09 mm, respectively (P<0.05). The morphologic investigation for apoptosis showed that the mixture of cisplatin and valproic acid has the highest apoptotic effect to a level of 81% on ovar-3 cell line compared to each of these compounds. Conclusion: Considering the significant synergistic apoptotic and lower cytotoxic effects of cisplatin and valproic acid drugs on ovary cells, the mixture of them can be an efficient antitumor compound targeting for treatment of ovar-3 cell line.

Synoptic, apoptotic and cytotoxic effects of cisplatin and valproic acid compounds on ovarian cancer cells